Enko Overview

  • Founded
  • 2017
Founded
  • Status
  • Private
  • Employees
  • 41
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $52.2M
Latest Deal Amount
  • Investors
  • 12

Enko General Information

Description

Developer of safe and sustainable small molecule technologies designed to address farmers' crop threats, from pest resistance to new diseases. The company's chemicals control agricultural pests, herbs, and fungus that damage the crop by producing toxic compounds and decreasing the quality of the crop, enabling farmers to maximize resource efficiency and minimize product hazards to get durable products for agricultural productivity.

Contact Information

Website
www.enkochem.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Agricultural Chemicals
Other Industries
Other Agriculture
Primary Office
  • 62 Maritime Drive
  • Mystic, CT 06355-1958
  • United States
+1 (978) 000-0000

Enko Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Enko Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 26-May-2021 $52.2M 000.00 0000 Completed Generating Revenue
2. Early Stage VC (Series A1) 13-Jul-2018 00.00 000.00 0000 Completed Generating Revenue
1. Early Stage VC (Series A) 30-May-2017 $6M $6M 0000 Completed Startup
To view Enko’s complete valuation and funding history, request access »

Enko Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B 00,000,000 00.000000 00.0 00.0 00 00.0 00.000
Series A1 0,000,000 00.000000 00.0 00.0 00 00.0 00.000
Series A 6,000,000 $0.000100 $1 $1 1x $1 12.57%
To view Enko’s complete cap table history, request access »

Enko Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of safe and sustainable small molecule technologies designed to address farmers' crop threats, from pest resis
Agricultural Chemicals
Mystic, CT
41 As of 2022
000.00
000 0000-00-00
0000000000 0 000.00

0000000

exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repr
000000000000 000000000
Santa Monica, CA
000 As of 0000
00000
0000 0000-00-00
00000000000 00000

0000 000

irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Except
000000000000 000000000
San Jose, CA
00 As of 0000
000.00
00.00 0000-00-00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Enko Competitors (16)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Provivi Venture Capital-Backed Santa Monica, CA 000 00000 00000000000 00000
0000 00000000000 Venture Capital-Backed San Jose, CA 00 000.00 00000000000 000.00
000000000 Venture Capital-Backed Vancouver, Canada 000 000.00 0000000000 000.00
00000 0000 Venture Capital-Backed Wigan, United Kingdom 0 00.000 0000000000 0 00.000
00000 000000 Venture Capital-Backed Saint Louis, MO 0000000000 0
You’re viewing 5 of 16 competitors. Get the full list »

Enko Executive Team (5)

Name Title Board Seat Contact Info
Jacqueline Heard Ph.D Co-Founder, Chief Executive Officer & Board Member
Brennan Doyle Chief Financial Officer
Thomas Meade Ph.D Chief Science Officer
David Jones Ph.D Chairperson
You’re viewing 4 of 5 executive team members. Get the full list »

Enko Board Members (6)

Name Representing Role Since
David Jones Ph.D Enko Chairperson 000 0000
Jacqueline Heard Ph.D Enko Co-Founder, Chief Executive Officer & Board Member 000 0000
Marijn Dekkers Ph.D Novalis LifeSciences Board Member 000 0000
Philip Austin Self Board Member 000 0000
Spencer Maughan Ph.D Finistere Ventures Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Enko Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Enko Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alumni Ventures Venture Capital Minority 000 0000 000000 0
Bill & Melinda Gates Foundation Not-For-Profit Venture Capital Minority 000 0000 000000 0
Bits x Bites Venture Capital Minority 000 0000 000000 0
Connecticut Innovations Venture Capital Minority 000 0000 000000 0
Finistere Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »

Ready to get started?

Request a free trial